3.0
Jun 23, 2026
Former employee, more than 10 years
London, England
Recommend
CEO approval
Business Outlook
Pros
Solid company, wide rage of roles, LTI and stock options
Cons
not great for development, mid to lower level pay vs other pharma companies, distant management mostly working remotely